Au, D., Lee, E. K., Popoola, T. O., Parker, W. P., Onge, J. M. S., & Ellis, S. D. (2021). Factors associated with utilization of neoadjuvant chemotherapy in charlson comorbidity zero non-metastatic muscle-invasive bladder cancer patients. International Brazilian Journal of Urology, 47(4), 803-818. https://doi.org/10.1590/s1677-5538.ibju.2020.0594
Citace podle Chicago (17th ed.)Au, Daniel, Eugene K. Lee, Taiye O. Popoola, William P. Parker, Jarron M. Saint Onge, a Shellie D. Ellis. "Factors Associated with Utilization of Neoadjuvant Chemotherapy in Charlson Comorbidity Zero Non-metastatic Muscle-invasive Bladder Cancer Patients." International Brazilian Journal of Urology 47, no. 4 (2021): 803-818. https://doi.org/10.1590/s1677-5538.ibju.2020.0594.
Citace podle MLA (9th ed.)Au, Daniel, et al. "Factors Associated with Utilization of Neoadjuvant Chemotherapy in Charlson Comorbidity Zero Non-metastatic Muscle-invasive Bladder Cancer Patients." International Brazilian Journal of Urology, vol. 47, no. 4, 2021, pp. 803-818, https://doi.org/10.1590/s1677-5538.ibju.2020.0594.